Absolute Antibody Ltd

Absolute Antibody was founded in 2012 with a vision to make engineered recombinant antibodies accessible to all, and we remain the only company 100% focused on recombinant antibody technology. Though recombinant antibodies are standard in the pharmaceutical industry, these antibodies have not been as widely available for diagnostics or research. This is starting to change, however, due to the many advantages recombinant antibodies offer over traditional hybridoma-produced monoclonal antibodies. We specialize in antibody sequencing, engineering and recombinant expression, offering royalty-free custom services and a unique reagents catalog of engineered recombinant antibodies and Fc Fusion proteins. Our customers include leading pharmaceutical, biotechnology and diagnostics companies, as well as academic researchers worldwide; we have customers in 65 different countries and have sold to 14 of the top 15 pharmaceutical companies by revenue.